{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:29:02Z","timestamp":1792801742871,"version":"4.5.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"King Gustaf V\u2019s 80-Year Fund","id":[{"id":"https:\/\/ror.org\/02szc9j24","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100007949","name":"the Swedish Rheumatism Association","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007949","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001862","name":"the Swedish Research Council","doi-asserted-by":"crossref","award":["K2013-52X-20307-07-3"],"award-info":[{"award-number":["K2013-52X-20307-07-3"]}],"id":[{"id":"10.13039\/501100001862","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002960","name":"V\u00e4sterbotten L\u00e4ns Landsting","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002960","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Swedish Foundation for Strategic Research","id":[{"id":"https:\/\/ror.org\/044wr7g58","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s13075-016-1031-0","type":"journal-article","created":{"date-parts":[[2016,6,2]],"date-time":"2016-06-02T21:04:05Z","timestamp":1464901445000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Antibodies directed against endogenous and exogenous citrullinated antigens pre-date the onset of rheumatoid arthritis"],"prefix":"10.1186","volume":"18","author":[{"given":"Linda","family":"Johansson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Pratesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikael","family":"Brink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisbeth","family":"\u00c4rlestig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"D\u2019Amato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debora","family":"Bartaloni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Migliorini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solbritt","family":"Rantap\u00e4\u00e4-Dahlqvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,6,3]]},"reference":[{"key":"1031_CR1","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/ncprheum0249","volume":"2","author":"L Klareskog","year":"2006","unstructured":"Klareskog L, Padyukov L, Lorentzen J, Alfredsson L. Mechanisms of disease: Genetic susceptibility and environmental triggers in the development of rheumatoid arthritis. Nat Clin Pract Rheumatol. 2006;2:425\u201333.","journal-title":"Nat Clin Pract Rheumatol."},{"key":"1031_CR2","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.autrev.2009.06.002","volume":"9","author":"C Anzilotti","year":"2010","unstructured":"Anzilotti C, Pratesi F, Tommasi C, Migliorini P. Peptidylarginine deiminase 4 and citrullination in health and disease. Autoimmun Rev. 2010;9:158\u201360.","journal-title":"Autoimmun Rev."},{"key":"1031_CR3","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/ar2903","volume":"12","author":"GJ Pruijn","year":"2010","unstructured":"Pruijn GJ, Wiik A, van Venrooij WJ. The use of citrullinated peptides and proteins for the diagnosis of rheumatoid arthritis. Arthritis Res Ther. 2010;12:203.","journal-title":"Arthritis Res Ther."},{"key":"1031_CR4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.0105-2896.2009.00853.x","volume":"233","author":"H Uysal","year":"2010","unstructured":"Uysal H, Nandakumar KS, Kessel C, et al. Antibodies to citrullinated proteins: molecular interactions and arthritogenicity. Immunol Rev. 2010;233:9\u201333.","journal-title":"Immunol Rev."},{"key":"1031_CR5","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1136\/ard.2010.138461","volume":"69","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ, et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Ann Rheum Dis. 2010;69:1580\u20138.","journal-title":"Ann Rheum Dis."},{"key":"1031_CR6","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1002\/art.11223","volume":"48","author":"S Rantap\u00e4\u00e4-Dahlqvist","year":"2003","unstructured":"Rantap\u00e4\u00e4-Dahlqvist S, de Jong BAW, Berglin E, et al. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum. 2003;48:2741\u20139.","journal-title":"Arthritis Rheum."},{"key":"1031_CR7","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/art.20018","volume":"50","author":"MMJ Nielen","year":"2004","unstructured":"Nielen MMJ, van Schaardenburg D, Reesink HW, et al. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum. 2004;50:380\u20136.","journal-title":"Arthritis Rheum."},{"key":"1031_CR8","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1002\/art.37835","volume":"65","author":"M Brink","year":"2013","unstructured":"Brink M, Hansson M, Mathsson L, et al. Multiplex analyses of antibodies against citrullinated peptides in individuals prior to development of rheumatoid arthritis. Arthritis Rheum. 2013;65:899\u2013910.","journal-title":"Arthritis Rheum."},{"key":"1031_CR9","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1002\/art.33489","volume":"64","author":"P Suwannalai","year":"2012","unstructured":"Suwannalai P, van de Stadt LA, Radner H, et al. Avidity maturation of anti-citrullinated protein antibodies in rheumatoid arthritis. Arthritis Rheum. 2012;64:1323\u20138.","journal-title":"Arthritis Rheum."},{"key":"1031_CR10","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/ng1010-814","volume":"42","author":"D Woude van der","year":"2010","unstructured":"van der Woude D, Alemayehu WG, Verduijn W, et al. Gene-environment interaction influences the reactivity of autoantibodies to citrullinated antigens in rheumatoid arthritis. Nat Genet. 2010;42:814\u20136. author reply 816.","journal-title":"Nat Genet."},{"key":"1031_CR11","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1136\/annrheumdis-2012-202352","volume":"72","author":"C Croia","year":"2013","unstructured":"Croia C, Serafini B, Bombardieri M, et al. Epstein-Barr virus persistence and infection of autoreactive plasma cells in synovial lymphoid structures in rheumatoid arthritis. Ann Rheum Dis. 2013;72:1559\u201368.","journal-title":"Ann Rheum Dis."},{"key":"1031_CR12","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.jbspin.2007.05.001","volume":"74","author":"E Toussirot","year":"2007","unstructured":"Toussirot E, Roudier J. Pathophysiological links between rheumatoid arthritis and the Epstein-Barr virus: an update. Joint Bone Spine. 2007;74:418\u201326.","journal-title":"Joint Bone Spine."},{"key":"1031_CR13","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1002\/art.33432","volume":"64","author":"N Dwivedi","year":"2012","unstructured":"Dwivedi N, Upadhyay J, Neeli I, et al. Felty\u2019s syndrome autoantibodies bind to deiminated histones and neutrophil extracellular chromatin traps. Arthritis Rheum. 2012;64:982\u201392.","journal-title":"Arthritis Rheum."},{"key":"1031_CR14","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1136\/annrheumdis-2012-202765","volume":"73","author":"F Pratesi","year":"2014","unstructured":"Pratesi F, Dioni I, Tommasi C, et al. Antibodies from patients with rheumatoid arthritis target citrullinated histone 4 contained in neutrophils extracellular traps. Ann Rheum Dis. 2014;73:1414\u201322.","journal-title":"Ann Rheum Dis."},{"key":"1031_CR15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1042\/BJ20140778","volume":"464","author":"A Neumann","year":"2014","unstructured":"Neumann A, Berends ETM, Nerlich A, et al. The antimicrobial peptide LL-37 facilitates the formation of neutrophil extracellular traps. Biochem J. 2014;464:3\u201311.","journal-title":"Biochem J."},{"key":"1031_CR16","doi-asserted-by":"crossref","unstructured":"Khandpur R, Carmona-Rivera C, Vivekanandan-Giri A, et al. NETs are a source of citrullinated autoantigens and stimulate inflammatory responses in rheumatoid arthritis. Sci Transl Med. 2013;5:178ra40.","DOI":"10.1126\/scitranslmed.3005580"},{"key":"1031_CR17","author":"E Corsiero","year":"2015","unstructured":"Corsiero E, Bombardieri M, Carlotti E, et al. Single cell cloning and recombinant monoclonal antibodies generation from RA synovial B cells reveal frequent targeting of citrullinated histones of NETs. Ann Rheum Dis. 2015. doi: 10.1136\/annrheumdis-2015-208356 .","journal-title":"Ann Rheum Dis"},{"key":"1031_CR18","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/art.21629","volume":"54","author":"F Pratesi","year":"2006","unstructured":"Pratesi F, Tommasi C, Anzilotti C, Chimenti D, Migliorini P. Deiminated Epstein-Barr virus nuclear antigen 1 is a target of anti-citrullinated protein antibodies in rheumatoid arthritis. Arthritis Rheum. 2006;54:733\u201341.","journal-title":"Arthritis Rheum."},{"key":"1031_CR19","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1365-2249.2011.04378.x","volume":"164","author":"F Pratesi","year":"2011","unstructured":"Pratesi F, Tommasi C, Anzilotti C, et al. Antibodies to a new viral citrullinated peptide, VCP2: fine specificity and correlation with anti-cyclic citrullinated peptide (CCP) and anti-VCP1 antibodies. Clin Exp Immunol. 2011;164:337\u201345.","journal-title":"Clin Exp Immunol."},{"key":"1031_CR20","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315\u201324.","journal-title":"Arthritis Rheum."},{"key":"1031_CR21","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1136\/ard.2005.041376","volume":"65","author":"E Berglin","year":"2006","unstructured":"Berglin E, Johansson T, Sundin U, et al. Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-RF at disease onset. Ann Rheum Dis. 2006;65:453\u20138.","journal-title":"Ann Rheum Dis."},{"key":"1031_CR22","doi-asserted-by":"crossref","unstructured":"Bruynesteyn K, Boers M, Kostense P, van der Linden S, and van der Heijde D. Deciding on progression of joint damage in paired films of individual patients: smallest detectable difference or change. Ann Rheum Dis. 2005;64:179-82.","DOI":"10.1136\/ard.2003.018457"},{"key":"1031_CR23","doi-asserted-by":"crossref","first-page":"R56","DOI":"10.1186\/ar2214","volume":"9","author":"H Kokkonen","year":"2007","unstructured":"Kokkonen H, Johansson M, Innala L, Jidell E, Rantapaa-Dahlqvist S. The PTPN22 1858C\/T polymorphism is associated with anti-cyclic citrullinated peptide antibody-positive early rheumatoid arthritis in northern Sweden. Arthritis Res Ther. 2007;9:R56.","journal-title":"Arthritis Res Ther."},{"key":"1031_CR24","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1038\/ng.2462","volume":"44","author":"S Eyre","year":"2012","unstructured":"Eyre S, Bowes J, Diogo D, et al. High-density genetic mapping identifies new susceptibility loci for rheumatoid arthritis. Nat Genet. 2012;44:1336\u201340.","journal-title":"Nat Genet."},{"key":"1031_CR25","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1086\/519795","volume":"81","author":"S Purcell","year":"2007","unstructured":"Purcell S, Neale B, Todd-Brown K, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81:559\u201375.","journal-title":"Am J Hum Genet."},{"key":"1031_CR26","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.imlet.2014.10.029","volume":"163","author":"IP Guzm\u00e1n-Guzm\u00e1n","year":"2015","unstructured":"Guzm\u00e1n-Guzm\u00e1n IP, Reyes-Castillo Z, Mu\u00f1oz-Barrios S, et al. Polymorphisms and functional haplotype in PADI4: further evidence for contribution on rheumatoid arthritis susceptibility and anti-cyclic citrullinated peptide antibodies in a western Mexican population. Immunol Lett. 2015;163:214\u201320.","journal-title":"Immunol Lett."},{"key":"1031_CR27","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/cei.12677","volume":"182","author":"Z Reyes-Castillo","year":"2015","unstructured":"Reyes-Castillo Z, Palafox-S\u00e1nchez CA, Parra-Rojas I, et al. Comparative analysis of autoantibodies targeting peptidylarginine deiminase type 4, mutated citrullinated vimentin and cyclic citrullinated peptides in rheumatoid arthritis: associations with cytokine profiles, clinical and genetic features. Clin Exp Immunol. 2015;182:119\u201331.","journal-title":"Clin Exp Immunol."},{"key":"1031_CR28","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1136\/ard.2004.026831","volume":"64","author":"L Caponi","year":"2005","unstructured":"Caponi L, Petit-Teixeira E, Sebbag M, et al. A family based study shows no association between rheumatoid arthritis and the PADI4 gene in a white French population. Ann Rheum Dis. 2005;64:587\u201393.","journal-title":"Ann Rheum Dis."},{"key":"1031_CR29","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1136\/ard.2009.124537","volume":"69","author":"D Woude van der","year":"2010","unstructured":"van der Woude D, Rantapaa-Dahlqvist S, Ioan-Facsinay A, et al. Epitope spreading of the anti-citrullinated protein antibody response occurs before disease onset and is associated with the disease course of early arthritis. Ann Rheum Dis. 2010;69:1554\u201361.","journal-title":"Ann Rheum Dis."},{"key":"1031_CR30","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s13075-015-0638-x","volume":"17","author":"H Kokkonen","year":"2015","unstructured":"Kokkonen H, Brink M, Hansson M, et al. Associations of antibodies against citrullinated peptides with human leukocyte antigen-shared epitope and smoking prior to the development of rheumatoid arthritis. Arthritis Res Ther. 2015;17:125.","journal-title":"Arthritis Res Ther."},{"key":"1031_CR31","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1002\/1529-0131(199907)42:7<1485::AID-ANR24>3.0.CO;2-7","volume":"42","author":"JG Saal","year":"1999","unstructured":"Saal JG, Krimmel M, Steidle M, et al. Synovial Epstein-Barr virus infection increases the risk of rheumatoid arthritis in individuals with the shared HLA-DR4 epitope. Arthritis Rheum. 1999;42:1485\u201396.","journal-title":"Arthritis Rheum."},{"key":"1031_CR32","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.3899\/jrheum.111548","volume":"39","author":"F Pratesi","year":"2012","unstructured":"Pratesi F, Petit-Teixeira E, Sidney J, et al. Effect of rheumatoid arthritis (RA) susceptibility genes on the immune response to viral citrullinated peptides in RA. J Rheumatol. 2012;39:1490\u20133.","journal-title":"J Rheumatol."},{"key":"1031_CR33","doi-asserted-by":"crossref","first-page":"R250","DOI":"10.1186\/ar4093","volume":"14","author":"CL Too","year":"2012","unstructured":"Too CL, Murad S, Dhaliwal JS, et al. Polymorphisms in peptidylarginine deiminase associate with rheumatoid arthritis in diverse Asian populations: evidence from MyEIRA study and meta-analysis. Arthritis Res Ther. 2012;14:R250.","journal-title":"Arthritis Res Ther."}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-016-1031-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T18:34:01Z","timestamp":1589654041000},"score":1,"resource":{"primary":{"URL":"http:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-016-1031-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,3]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["1031"],"URL":"https:\/\/doi.org\/10.1186\/s13075-016-1031-0","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,3]]},"article-number":"127"}}